Mirae Asset Global Investments
DSGN icon

Mirae Asset Global Investments’s Design Therapeutics DSGN Stock Holding History

Mirae Asset Global Investments’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.4K Sell
2,793
-178
-6% -$2.22K ﹤0.01% 1391
2026
Q1 		$31.6K Buy
2,971
+203
+7% +$2.05K ﹤0.01% 1374
2025
Q4 		$26K Buy
2,768
+566
+26% +$4.43K ﹤0.01% 1503
2025
Q3 		$16.6K Buy
2,202
+9
+0.4% +$45 ﹤0.01% 1514
2025
Q2 		$7.39K Buy
2,193
+298
+16% +$1.11K ﹤0.01% 1522
2025
Q1 		$7.98K Buy
1,895
+8
+0.4% +$38 ﹤0.01% 1490
2024
Q4 		$11.8K Buy
+1,887
New +$10.9K ﹤0.01% 1494
2024
Q2 		– Sell
-14,133
Closed -$77.7K – 1799
2024
Q1 		$77.7K Buy
+14,133
New +$37.7K ﹤0.01% 2397
2023
Q3 		– Sell
-15,398
Closed -$97K – 2590
2023
Q2 		$97K Sell
15,398
-114
-0.7% -$698 ﹤0.01% 2519
2023
Q1 		$89.5K Sell
15,512
-36
-0.2% -$269 ﹤0.01% 2462
2022
Q4 		$160K Buy
15,548
+22
+0.1% +$298 ﹤0.01% 2351
2022
Q3 		$259K Buy
+15,526
New +$309K ﹤0.01% 2226

Other funds holding DSGN

CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Mirae Asset Global Investments's DSGN Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Design Therapeutics (DSGN) stake by 6% in Q2 2026, selling an estimated $2.22K and leaving 2,793 shares worth $40.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Mirae Asset Global Investments first reported a position in DSGN in Q3 2022 and has held it in 12 quarters since. The position peaked at $259K in Q3 2022. 23 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Mirae Asset Global Investments held 2,793 shares of Design Therapeutics worth $40.4K as of Q2 2026.
  • Mirae Asset Global Investments sold 178 Design Therapeutics shares in Q2 2026, an estimated $2.22K.
  • Design Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1391 holding.
  • Mirae Asset Global Investments first reported a position in Design Therapeutics in Q3 2022 and has held it in 12 quarters since.
  • Mirae Asset Global Investments's Design Therapeutics position peaked at $259K in Q3 2022.
  • 23 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.